Itraconazole pulse therapy is effective in the treatment of tinea capitis in children: an open multicentre study

被引:43
作者
Gupta, AK
Alexis, ME
Raboobee, N
Hofstader, SLR
Lynde, CW
Adam, P
Summerbell, RC
DeDoncker, P
机构
[1] SUNNYBROOK HLTH SCI CTR,DEPT MED,DIV DERMATOL,TORONTO,ON M4N 3M5,CANADA
[2] UNIV TORONTO,DEPT MICROBIOL,TORONTO,ON,CANADA
[3] KING EDWARD VIII HOSP,DEPT DERMATOL,DURBAN,SOUTH AFRICA
[4] UNIV NATAL,ZA-4001 DURBAN,SOUTH AFRICA
[5] WOMENS COLL HOSP,DEPT MED,DIV DERMATOL,TORONTO,ON M5S 1B2,CANADA
[6] TORONTO WESTERN HOSP,DEPT MED,DIV DERMATOL,TORONTO,ON M5T 2S8,CANADA
[7] ST MICHAELS HOSP,DEPT MED,DIV DERMATOL,TORONTO,ON M5B 1W8,CANADA
[8] ONTARIO MINIST HLTH,MYCOL LAB,TORONTO,ON M5W 1R5,CANADA
[9] JANSSEN RES FDN,B-2340 BEERSE,BELGIUM
关键词
D O I
10.1046/j.1365-2133.1997.18141912.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
In an open multicentre study we have demonstrated that itraconazole pulse therapy, 5 mg/kg per day, is effective and safe in the management of tinea capitis in 10 children (seven boys, three girls, mean age: 6.6 years, age range 4-11 years), The causative organisms were Trichophyton tonsurans (six cases), T. violaceum (two cases), T. soudanense (one case) and Microsporum gypseum (one case), Each pulse of drug therapy lasted 1 week with 2 weeks off between consecutive pulses, One, two and three pulses produced complete, clinical and mycological, cure in one, six and three patients, respectively, The children tolerated the treatment well and there were no clinical or laboratory adverse effects, This 1-week pulse therapy regimen resulted in a high degree of compliance. The preliminary results of this study are promising and need to be evaluated in a larger sample of patients.
引用
收藏
页码:251 / 254
页数:4
相关论文
共 23 条
[1]   PHARMACOKINETIC PROFILE OF ORALLY-ADMINISTERED ITRACONAZOLE IN HUMAN-SKIN [J].
CAUWENBERGH, G ;
DEGREEF, H ;
HEYKANTS, J ;
WOESTENBORGHS, R ;
VANROOY, P ;
HAEVERANS, K .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1988, 18 (02) :263-268
[2]  
Degreef H, 1996, CUTIS, V58, P90
[3]  
Desgarennes MDP, 1996, J AM ACAD DERMATOL, V35, P114, DOI 10.1016/S0190-9622(96)90522-8
[4]   TINEA-CAPITIS - ITRACONAZOLE IN TRICHOPHYTON-TONSURANS INFECTION [J].
ELEWSKI, BE .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1994, 31 (01) :65-67
[5]  
FRANKS AG, 1956, ARCH DERMATOL, V74, P348
[6]   DIAGNOSIS AND MANAGEMENT OF TINEA-CAPITIS [J].
FRIEDEN, IJ .
PEDIATRIC ANNALS, 1987, 16 (01) :39-&
[7]   EPIDEMIOLOGY AND TREATMENT OF TINEA-CAPITIS - KETOCONAZOLE VS GRISEOFULVIN [J].
GAN, VN ;
PETRUSKA, M ;
GINSBURG, CM .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1987, 6 (01) :46-49
[8]   Treatment of tinea capitis with itraconazole [J].
Greer, DL .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996, 35 (04) :637-638
[9]   Onychomycosis in children: Prevalence and treatment strategies [J].
Gupta, AK ;
Sibbald, RG ;
Lynde, CW ;
Hull, PR ;
Prussick, R ;
Shear, NH ;
DeDoncker, P ;
Daniel, CR ;
Elewski, BE .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 36 (03) :395-402
[10]   ANTIFUNGAL AGENTS - AN OVERVIEW .1. [J].
GUPTA, AK ;
SAUDER, DN ;
SHEAR, NH .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1994, 30 (05) :677-698